The story of our birth

Nuvo was born in 2014 at the same time as my third child. My wife was 37 weeks pregnant and became high risk. We suffered a lot of stress because of outdated pregnancy monitoring and medical practice. Thankfully, our baby was born healthy, but the experience left me with a burning desire to offer parents a more complete sense of their journey and reinvent pregnancy monitoring from the ground up. At that moment, I suddenly realized there had to be a better way to help free women from the wall and the worry. That’s why today Nuvo is driven by this vision, using the best technology available.
Oren Oz
NuvoTM Founder

Our team

Meet the pioneers with a passion for transforming pregnancy care.

The Leadership Team

Kelly Londy

Kelly is a seasoned healthcare leader with a track record of commercialization success. She has CEO experience at early-stage medical device companies and has also held various leadership positions at Accuray, Inc., GE's medical systems and healthcare divisions, and Philips Healthcare North America.

Amit Reches
Chief Technology Officer
Amit leads algorithms, data science, machine learning, hardware and clinical affairs activities at NuvoTM. He is a seasoned research and development executive with over 15 years of experience in the medical device domain.
Orly Hirsch
Vice President, People
Orly focuses on every aspect of the people at NuvoTM to create an employee experience that will achieve success. She has extensive experience driving and facilitating organizational growth and transformation in global, multicultural business environments, as well as startup organizations.
Dotan Raviv
Vice President, Operations
Dotan leads global Operations which comprises Operations, IT & Program Management with the mission to ensure delivery on promises while applying operational excellence on all ends. Previously Dotan led a variety of projects in the technology sector, from small systems to mega projects.
Noah Klein
Vice President, Business Development
Noah leads Nuvo's Business Development from the Israel corporate headquarters, developing and focusing Nuvo's commercial strategies and helping bring to initial execution. He has experience in startups, enterprise sales, and product-market strategy.
Keren Shalev
Vice President - Product

Keren leads product management, product marketing, product training and customer experience activities at Nuvo, dedicated to building a product that supports Nuvo’s go-to-market strategy. With over a decade of leading roles in product management, software development and digital transformation, Keren has extensive experience delivering products from concept to implementation.

Ryan Kraudel
Vice President, Marketing
Ryan leads global marketing for Nuvo and is responsible for all areas of marketing strategy and execution. He has over 20 years of marketing experience and has a strong track record of growing large and small organizations to achieve revenue and valuation targets.

The Board of Directors

Laurence Klein

Laurence previously served as founder and CEO of several award-winning startups. He currently operates a private equity fund, as well as advising and sitting on the boards of various companies.

Oren Oz

Oren is the founder of NuvoTM. A data scientist, entrepreneur and dad, the company was inspired by his wife’s experience during pregnancy. Before NuvoTM, Oren started and led a variety of entrepreneurial ventures, primarily in technology.

Gerald M. Ostrov, MBA

Gerald previously served as Chairman & Chief Executive Officer of Bausch & Lomb, Inc., Group Chairman of Johnson & Johnson, and President of CIBA Consumer Pharmaceuticals.

Rice Powell

Rice Powell is former Chief Executive Officer and Chairman of the Management Board of Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure.

Prior to becoming chief executive officer, he was vice chairman of the management board and member of the management board responsible for the North American region from 2010 through 2012. Powell joined Fresenius Medical Care in 1997 and was appointed to the company's management board and co-chief executive officer of Fresenius Medical Care North America in 2004.

Powell has more than 36 years of experience in the healthcare industry. Between 1978 and 1996, he held a number of positions at Baxter International Inc. and Biogen Inc. in the United States.

The Advisory Board

Steve Bonner
Strategic Advisor

Steve is the former CEO, President and Executive Chairman of Cancer Treatment Centers of America and former Entrepreneur in Residence at Harvard Business School. Steve is a long time advocate for consumer-centric, quality-driven healthcare transformation that empowers patients with clear and thorough information and puts them at the center of their medical decisions.

Michael Butchko
Strategic Advisor

Michael is the former SVP & General Manager of ultrasound at GE Healthcare. He has expertise in commercial development, global business management, sales and marketing, strategic operations, and cross-functional team leadership, across the medical device and healthcare solutions markets.

Dr. Joshua Copel, MD
Strategic Advisor

Dr. Copel is Professor, Obstetrics, Gynecology & Reproductive Services, and Pediatrics at Yale School of Medicine. He brings over 30 years of experience to women’s health with a concentration in Obstetrics and Gynecology. He is a past President of American Institute of Ultrasound Medicine and Society for Maternal-Fetal Medicine.

Deb Henretta

Deb has spent 30 years at Procter & Gamble (P&G), successfully growing and leading several of the company’s multi-billion-dollar businesses. During her tenure with P&G, she also served as Group President and Senior Executive Officer for P&G’s $20 billion Beauty Business, its $20 billion Asian Business, and its $14 billion Baby Care Business. Deb is currently a partner at G100 Companies.

Deb spent seven consecutive years on Fortune’s U.S. and International rankings of the 50 Most Powerful Women in Business.

Dr. Lawrence D. Platt, MD
Medical Advisor

In addition to his private practice work, Dr. Platt is a Clinical Professor in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA.

Denise Napier
Strategic Advisor

Denise serves as the President and Chief Executive Officer of Health Partners Plans and brings over fifteen years of experience working at or with payers.

Dr. Jack Rychik, MD
Medical Advisor

Dr. Rychik is the director of the Fetal Heart Program and Single Ventricle Survivorship Program at the Children’s Hospital of Philadelphia.

Dr. David Shulkin, MD
Strategic Advisor

Dr. Shulkin is Former Secretary of Veterans Affairs (VA) and Former President and CEO of Beth Israel Medical Center in New York City. He works with leading healthcare organizations and companies to foster innovation and improve well-being for patients.

Dr. Steven Warsof, MD
Strategic Advisor

Prof. Warsof is on the faculty at Eastern Virginia Medical School’s Division of Maternal Fetal Medicine where he serves as Director of Genetics and Prenatal Diagnosis. He is also a visiting professor at the Bar Ilan University Medical School.

Prof. Simcha Yagel, MD
Medical Advisor

Prof. Yagel is presently the Head of the Division of Obstetrics and Gynecology of Hadassah-Hebrew University Medical Centers, Jerusalem. He has performed a wide range of research in obstetric and gynecological ultrasound.

Why we care

Pregnancy care is outdated and ripe for disruption. Here are some reasons why we are leading the shift from hospital to home.

Pregnancy management
is disruption-ready

  • The high cost of care is unsustainable
  • High-risk pregnancies are more likely due to the rising age of mothers-to-be, high BMI, and growing complications
  • Half of U.S. counties lack a single OB/GYN specialist due to a critical shortage

Existing technology is outdated

  • Pregnancy monitoring, Doppler and CTG, is 30 years old and unchanged
  • Existing solutions have a 35% failure rate for measuring contractions
  • Maternal-fetal data is limited, fragmented, and available only during doctor visits
  • Fails to meet expectations of highly connected millennial parents

Remote monitoring has proved to
reduce costs and improve outcomes

  • Prolonging pregnancy closer to term
  • Higher birth weight
  • Reduced fetal mortality
  • Increased patient satisfaction

Meet us at a conference

Here's where we'll be in 2023. Be sure to say "hello" and join our movement to revolutionize maternity care:

ACOG 2023

May 19-21, 2023

Baltimore, MD

ATA Conference 2023

March 4-6, 2023

San Antonio, TX

Join the #MaternityMovement now.

Get updates on what we're doing and how you can help.